Pancreatic Enzyme Replacement Therapy – Guide
Pancreatic enzyme replacement therapy (PERT) supplies digestive enzymes when the pancreas can no longer produce enough. It improves nutrient absorption and relieves symptoms such as fatty stools and weight loss.
Things worth knowing about "Pancreatic Enzyme Replacement Therapy"
Pancreatic enzyme replacement therapy (PERT) supplies digestive enzymes when the pancreas can no longer produce enough. It improves nutrient absorption and relieves symptoms such as fatty stools and weight loss.
What is Pancreatic Enzyme Replacement Therapy?
Pancreatic enzyme replacement therapy (PERT) is a medical treatment in which artificially supplied digestive enzymes compensate for the reduced or absent natural enzyme production of the pancreas. It is indicated when the pancreas can no longer produce sufficient enzymes to fully break down and absorb nutrients from food – a condition known as exocrine pancreatic insufficiency (EPI).
Causes of Exocrine Pancreatic Insufficiency
Several underlying conditions can make pancreatic enzyme replacement therapy necessary:
- Chronic pancreatitis: Long-term inflammation of the pancreas, often caused by alcohol or gallstones
- Cystic fibrosis: A genetic disorder associated with markedly reduced enzyme secretion
- Pancreatic cancer: Destruction of glandular tissue by malignant disease
- Pancreatic surgery: Partial or total removal of the pancreas (e.g., Whipple procedure)
- Type 3c diabetes mellitus: Pancreatogenic diabetes resulting from pancreatic disease
Symptoms of Exocrine Pancreatic Insufficiency
Without adequate enzyme activity, fats, proteins, and carbohydrates cannot be properly digested. Common symptoms include:
- Fatty, foul-smelling stools (steatorrhoea)
- Diarrhoea and bloating
- Unintentional weight loss
- Malnutrition and vitamin deficiencies (especially fat-soluble vitamins A, D, E, and K)
- Abdominal pain and cramping after meals
- Muscle weakness and general fatigue
Diagnosis
Several tests are used to confirm exocrine pancreatic insufficiency:
- Faecal elastase-1 test: Measures the enzyme elastase in stool – low levels indicate insufficiency
- 72-hour faecal fat test: Directly quantifies fat loss in stool
- Imaging studies: Ultrasound, CT, or MRI to assess pancreatic tissue
- Breath tests: Such as the 13C-mixed triglyceride breath test for functional assessment
Mechanism of Action
PERT preparations typically contain pancreatin, a mixture of digestive enzymes derived from animal sources (usually porcine, i.e., from pigs):
- Lipases: Break down fats into fatty acids and glycerol
- Amylases: Digest carbohydrates (starches)
- Proteases: Break down protein molecules into amino acids
Most preparations are formulated as enteric-coated microspheres or minitablets enclosed in gelatin capsules. This coating protects the enzymes from stomach acid and ensures they are released only in the small intestine, where digestion takes place.
Dosage and Administration
Enzyme dosage is based on the fat content of the meal and the individual severity of insufficiency. General recommendations include:
- Enzymes should be taken at the start of a meal or distributed throughout the meal
- For main meals, 25,000–80,000 lipase units are typically recommended
- Smaller doses (e.g., 10,000–25,000 units) are usually sufficient for snacks
- Capsules should not be chewed; the contents may be sprinkled onto soft food if needed
- Dosing is individualised and monitored by a physician
Side Effects
Pancreatic enzyme preparations are generally well tolerated. Possible side effects include:
- Nausea, vomiting, or abdominal pain (usually with excessive dosing)
- Diarrhoea or constipation
- Skin reactions (rare, in cases of hypersensitivity to porcine proteins)
- At very high doses: fibrosing colonopathy (scarring of the colon) – primarily reported in children with cystic fibrosis
- Elevated uric acid levels with prolonged high-dose therapy
Treatment Success and Quality of Life
With correctly adjusted PERT, most patients experience a significant improvement in symptoms. Weight gain, normalisation of bowel movements, and resolution of vitamin deficiencies are typical signs of treatment success. Regular follow-up (blood counts, vitamin levels, body weight) is important to optimise therapy over time.
References
- Löhr J. M. et al. - United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. United European Gastroenterology Journal, 2017.
- Dominguez-Munoz J. E. - Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Gastroenterology & Hepatology, 2011.
- Whitcomb D. C., Lowe M. E. - Human pancreatic digestive enzymes. Digestive Diseases and Sciences, 2007.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryChlorine dioxide
Calorie expenditure
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Pancreatic Enzyme Replacement Therapy-en